Your browser doesn't support javascript.
loading
In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014).
de Jonge, Boudewijn L M; Karlowsky, James A; Kazmierczak, Krystyna M; Biedenbach, Douglas J; Sahm, Daniel F; Nichols, Wright W.
Afiliação
  • de Jonge BL; AstraZeneca Pharmaceuticals, Waltham, Massachusetts, USA.
  • Karlowsky JA; International Health Management Associates, Inc., Schaumburg, Illinois, USA.
  • Kazmierczak KM; International Health Management Associates, Inc., Schaumburg, Illinois, USA kkazmierczak@ihmainc.com.
  • Biedenbach DJ; International Health Management Associates, Inc., Schaumburg, Illinois, USA.
  • Sahm DF; International Health Management Associates, Inc., Schaumburg, Illinois, USA.
  • Nichols WW; AstraZeneca Pharmaceuticals, Waltham, Massachusetts, USA.
Antimicrob Agents Chemother ; 60(5): 3163-9, 2016 05.
Article em En | MEDLINE | ID: mdl-26926648

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbapenêmicos / Ceftazidima / Enterobacteriaceae / Compostos Azabicíclicos Tipo de estudo: Screening_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carbapenêmicos / Ceftazidima / Enterobacteriaceae / Compostos Azabicíclicos Tipo de estudo: Screening_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article